EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mouse Models of Osteosarcoma: Unraveling Disease Mechanisms and Accelerating Drug Discovery and Development

Staci L Haney iD, Sarah A Holstein iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70390 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Reports, 2025. Verfasst von Staci L Haney und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, Neoplasms, Experimental, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcoma is the most frequent primary bone malignancy, affecting mainly children, adolescents, and young adults. For the past 40 years, improvements in the survival of patients with osteosarcoma have been minimal, primarily as a consequence of the lack of systemic therapy options beyond traditional cytotoxic agents. In particular, management of metastatic and recurrent disease continues to be a significant clinical challenge. Recent Findings Mouse models of osteosarcoma serve as a valuable tool to study disease biology, metastasis, and response to novel treatments. In recent years, mouse models have been employed to evaluate the efficacy of several innovative drugs, including nanoparticle formulations that can target drug delivery to osteosarcoma tumor cells and diminish off‐target effects. In addition, significant preclinical advancements in immune checkpoint inhibitors and immunotherapies for osteosarcoma have been made with the aid of mouse models.

Conclusion

This review provides insight into the advantages and shortcomings of the numerous osteosarcoma mouse models described in the literature, including transgenic, orthotopic, and heterotopic models as well as patient‐derived xenografts. We highlight how these models are currently being used to support preclinical studies focused on the development of novel therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsNeoplasms, ExperimentalLung NeoplasmsDrug DevelopmentAnimalsMiceMice, TransgenicXenograft Model Antitumor AssaysCell Line, TumorAntineoplastic AgentsHumansDrug DiscoveryImmune Checkpoint InhibitorsOncogene ProteinsTumor Suppressor Proteins

Substanzen

Antineoplastic AgentsImmune Checkpoint InhibitorsOncogene ProteinsTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

ORCID-Profile: Staci L Haney, Sarah A Holstein

Zitieren

APA

Haney, S. L., & Holstein, S. A. (2025). Mouse Models of Osteosarcoma: Unraveling Disease Mechanisms and Accelerating Drug Discovery and Development. Cancer Reports. https://doi.org/10.1002/cnr2.70390

Vancouver

Haney SL, Holstein SA. Mouse Models of Osteosarcoma: Unraveling Disease Mechanisms and Accelerating Drug Discovery and Development. Cancer Reports. 2025. doi:10.1002/cnr2.70390

BibTeX
@article{Haney2025,
  author = {Haney, Staci L and Holstein, Sarah A},
  title = {Mouse Models of Osteosarcoma: Unraveling Disease Mechanisms and Accelerating Drug Discovery and Development},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70390}
}
Kostenlos starten →